Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lucia Martina Silvestri"'
Autor:
Marta eUnolt, Carolina ePutotto, Lucia Martina Silvestri, Dario eMarino, Alessia eScarabotti, Valerio eMassaccesi, Angela eCaiaro, Paolo eVersacci, Bruno eMarino
Publikováno v:
Frontiers in Pediatrics, Vol 1 (2013)
Transposition of great arteries (TGA) is one of the most common and severe congenital heart diseases (CHD). It is also one of the most mysterious CHD because it has no precedent in phylogenetic and ontogenetic development, it does not represent an al
Externí odkaz:
https://doaj.org/article/65791f469f844736a77c677c4e055e41
Autor:
Lucia Pacifico, Paolo Versacci, M. Di Martino, Gianmarco Andreoli, Enea Bonci, Claudio Chiesa, Lucia Martina Silvestri
Publikováno v:
NMCD. Nutrition Metabolism and Cardiovascular Diseases (Testo stamp.) 25 (2015): 734–741. doi:10.1016/j.numecd.2015.04.003
info:cnr-pdr/source/autori:Pacifico, L.; Bonci, E.; Di Martino, M.; Versacci, P.; Andreoli, G.; Silvestri, L. M.; Chiesa, C./titolo:A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease/doi:10.1016%2Fj.numecd.2015.04.003/rivista:NMCD. Nutrition Metabolism and Cardiovascular Diseases (Testo stamp.)/anno:2015/pagina_da:734/pagina_a:741/intervallo_pagine:734–741/volume:25
info:cnr-pdr/source/autori:Pacifico, L.; Bonci, E.; Di Martino, M.; Versacci, P.; Andreoli, G.; Silvestri, L. M.; Chiesa, C./titolo:A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease/doi:10.1016%2Fj.numecd.2015.04.003/rivista:NMCD. Nutrition Metabolism and Cardiovascular Diseases (Testo stamp.)/anno:2015/pagina_da:734/pagina_a:741/intervallo_pagine:734–741/volume:25
Background and Aims Very little information is available on whether docosahexaenoic acid (DHA) supplementation has a beneficial effect on liver fat and cardiovascular disease (CVD) risk factors in children with nonalcoholic fatty liver disease (NAFLD
Autor:
Enea Bonci, Caterina Anania, Claudio Chiesa, Lucia Pacifico, Lucia Martina Silvestri, Paolo Versacci
Publikováno v:
BioMed Research International
BioMed Research International (Online) 2015 (2015): Article ID 213737. doi:10.1155/2015/213737
info:cnr-pdr/source/autori:1 Bonci E, 2 Chiesa C, 3 Versacci P, 3 Anania C, 3 Silvestri L, 3 Pacifico L/titolo:Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis/doi:10.1155%2F2015%2F213737/rivista:BioMed Research International (Online)/anno:2015/pagina_da:Article ID 213737/pagina_a:/intervallo_pagine:Article ID 213737/volume:2015
BioMed Research International, Vol 2015 (2015)
BioMed Research International (Online) 2015 (2015): Article ID 213737. doi:10.1155/2015/213737
info:cnr-pdr/source/autori:1 Bonci E, 2 Chiesa C, 3 Versacci P, 3 Anania C, 3 Silvestri L, 3 Pacifico L/titolo:Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis/doi:10.1155%2F2015%2F213737/rivista:BioMed Research International (Online)/anno:2015/pagina_da:Article ID 213737/pagina_a:/intervallo_pagine:Article ID 213737/volume:2015
BioMed Research International, Vol 2015 (2015)
In the last 20 years, nonalcoholic fatty liver disease (NAFLD) has become the leading cause of chronic liver disease worldwide, primarily as a result of the epidemic of obesity. NAFLD is strongly associated with insulin resistance, glucose intoleranc
Publikováno v:
Pediatric cardiology. 35(6)
To the Editor, We read with great interest the report by Cramer et al. [3] on the spectrum of congenital heart disease (CHD) and outcomes after surgical repair in children with Turner syndrome (TS). In their retrospective single-center review, the au
Publikováno v:
The Tricuspid Valve in Congenital Heart Disease ISBN: 9788847053991
Ebstein anomaly (EA) is a rare etiologically heterogeneous congenital malformation of the tricuspid valve, accounting for less than 1 % of all congenital heart defects (CHDs) and for 0.3–0.8 % of all patients presenting with CHD in the first year o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bc561a6cf6a734471a5659f61cbd532
https://doi.org/10.1007/978-88-470-5400-4_3
https://doi.org/10.1007/978-88-470-5400-4_3
Publikováno v:
American Journal of Medical Genetics Part A. 164:1340-1340